Decreased Androgen Levels and Obesity in Men

References

• Rissanen A, Heliövaara M, Knekt P, Reunanen A, Aromaa A, Maatila J. Risk of disability and mortality due to overweight in a Finnish population. BMJ 1990; 301: 835–7
   PubMed Web of Science ®Google Scholar
• Wannamathaa G, Shaper A G. Body weight and mortality in middle-aged British men. BMJ 1989; 299: 1497–502
   Google Scholar
• Vague J. The degree of masculine differentiation of obesities. Am J Clin Nutr 1956; 4: 20–34
   PubMed Web of Science ®Google Scholar
• Hartz A J, Rupley D C, Rimm A A. The association of girth measurement with disease in 32.856 women. Am J Epidemiol 1984; 119: 71–80
   PubMed Web of Science ®Google Scholar
• Kissebah, Vydelingum N, Murray R, et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982; 54: 254–60
   PubMed Web of Science ®Google Scholar
• Zumoff A, Strain W, Miller J K, et al. Plasma free and non sex hormone binding globulin bound testosterone are decreased in obese men in proportion of their degree of obesity. J Clin Endocrinol Metab 1990; 71: 929–31
   PubMed Web of Science ®Google Scholar
• Giagulti V A, Kaufman J M, Vermeulen A. Pathogenesis of increased androgen levels in obese men. J Clin Endocrinol Metab 1994; 79: 997–1000
   Google Scholar
• Evans D J, Hoffman R G, Kalkhoff R F, Kissebah A H. Relationship of androgenic activity to body fat topography, fat cell morphology and metabolic aberrations in premenopausal women. J Clin Endocrinol Metab 1983; 57: 304–10
   PubMed Web of Science ®Google Scholar
• Peiris A N, Sothman M S, Arman E J. Kissebah AH. The relationship of insulin to sex hormone binding globulin: role of adiposity. Fertil Steril 1989; 52: 69–72
   PubMedGoogle Scholar
• Plymate S R, Matej L A, Jones R E, Friedl R E. Inhibition of sex hormone binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab 1988; 67: 460–4
   PubMed Web of Science ®Google Scholar
• Rubens R, Dhont L, Vermeulen A. Further studies on Leydig cell function in old age. J Clin Endocrinol Metab 1974; 39: 40–5
   PubMed Web of Science ®Google Scholar
• Vermeulen A, Kaufman J M, Deslypere J P, Thomas G. Attenuated luteinizing hormone (LH) pulse amplitude but normal LH pulse frequency and its relation to plasma androgens in hypogonadism of obese men. J Clin Endocrinol Metab 1993; 76: 1140–6
   PubMed Web of Science ®Google Scholar
• Strain G, Zumoff B, Rosner W, Pi-Sunyer X. The relationship between serum levels of insulin and sex hormone binding globulin in men – the effect of weight loss. J Clin Endocrinol Metab 1994; 79: 1173–6
   PubMed Web of Science ®Google Scholar
• O'Dea J P, Wieland R G, Hallberg M C, Llerena L A, Zorn E M, Genuth S M. Effect of dietary weight Joss on sex steroid binding, sex steroids and gonadotropins in obese premenopausal women. J Lab Clin Med 1991; 93: 1004–8
   Google Scholar
• Iranmanesh A, Lizarralde G, Veldhuis J D. Age and relative adiposity are negative determinants of frequency and amplitude of growth hormone (GH) secretory bursts and the half life of endogenous GH in healthy men. J Clin Endocrinol Metab 1991; 73: 1081–8
   PubMed Web of Science ®Google Scholar
• De Moor P, Heyns W, Bouillon R. Growth hormone and steroid binding β globulin of human plasma. J Steroid Biochem 1972; 3: 593–600
   Google Scholar
• Vermeulen A, Rubens R, Verdonck L. Testosterone secretion and metabolism in male senescence. J Clin Endocrinol Metab 1972; 34: 730–40
   PubMed Web of Science ®Google Scholar
• Nestler J E, Usiskin R S, Barlascini C O, Welty D F, Clore J N, Blackard W G. Suppression of serum dehydroepiandrosterone sulfate levels by insulin: an evaluation of possible mechanisms. J Clin Endocrinol Metab 1989; 69: 1040–6
   PubMed Web of Science ®Google Scholar
• Nestler J E, Beer N A, Jakubowicz D J, Beer R M. Effects of reduction of circulating insulin by Metformin on serum dehydroepiandrosterone sulfate in non-diabetic men. J Clin Endocrinol Metab 1994; 76: 551–4
   Google Scholar
• De Pergola G, Giagulli V A, Garruti G, et al. Low dehydroepiandrosterone circulatory levels in premenopausal obese women with very high body mass index. Metabolism 1991; 40: 187–90
   PubMedGoogle Scholar
• Ritmaster R S, Desheval N, Lehman L. The role of adrenal hyperandrogenism, insulin resistance and obesity in the pathogenesis of the polycystic ovary syndrome. J Clin Endocrinol Metab 1993; 76: 1295–300
   Google Scholar
• Phillips C B. Relationship between sex hormones and the glucose-insulin-lipid defect in men with obesity. Metabolism 1993; 42: 116–20
   PubMed Web of Science ®Google Scholar
• Parker R, Odell W. Evidence for a cortical androgen stimulating hormone. Am J Physiol 1979; 236: E616–20
   PubMed Web of Science ®Google Scholar
• Kley A K, Krüskemper H L. Gesamt und freies Testosteron beim Mann in Abhängigkeit vom Körpergewicht. Dtsch Med Wochenschr 1979; 104: 1478–82
   Google Scholar
• Strain G W, Zumoff B, Kream J, et al. Mild hypogonadotropic hypogonadism in obese men. Metabolism 1982; 31: 871–5
   PubMed Web of Science ®Google Scholar
• Märin P, Holmäng S, Jönsson L, et al. The effect of testosterone treatment on body composition and metabolism in middle-aged obese men. Intern J Obes 1992; 16: 991–2
   PubMed Web of Science ®Google Scholar